共 230 条
[1]
Bowles EJ(2012)Endocrine therapy initiation from 2001 to 2008 varies by age at breast cancer diagnosis and tumor size J Oncol Pract 8 113-120
[2]
Buist DS(2017)Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer Breast Cancer Res Treat 163 311-319
[3]
Chubak J(2013)Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication Breast Cancer Res Treat 137 829-836
[4]
Yu O(2018)Oral endocrine therapy nonadherence, adverse effects, decisional support, and decisional needs in women with breast cancer Cancer Nurs 41 E9-E18
[5]
Johnson J(2017)Extended adjuvant endocrine therapy in breast cancer: evidence and update—a review Breast J 23 694-705
[6]
Chestnut J(2014)Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry Breast Cancer Res Treat 145 525-534
[7]
Boudreau DM(2016)Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer Breast Cancer Res Treat 158 243-251
[8]
Salgado TM(2014)A hard pill to swallow: a qualitative study of women’s experiences of adjuvant endocrine therapy for breast cancer BMJ Open 4 e005285-537
[9]
Davis EJ(2018)Factors associated with intentional and unintentional non-adherence to adjuvant endocrine therapy following breast cancer Eur J Cancer Care 27 e12601-1524
[10]
Farris KB(2011)Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer Breast Cancer Res Treat 126 529-e137